CD4 and neoplasm: Recent data have shown that MDSCs are the chief controllers of cancer immune responses and inflammation in individuals with tumours as they intensely constrain the antitumor immune response of CD4+ T cells, CD8+ T cells and NK cells, thus triggering tumour growth.